East Windsor, NJ – Aurobindo Pharma has received approval from the U.S. Food and Drug Administration
for its abbreviated new drug application for Tizanidine Hydrochloride capsules. Aurobindo’s Tizanidine
Hydrochloride capsules are an AB-rated generic that is equivalent to the brand drug Zanaflex® and will
be available in 2 mg, 4 mg, and 6 mg dose presentations.